AltShares并购套利ETF ARB 深 沪

传统券商入局加密赛道 Robinhood布局以太坊二层网络

Robinhood与Arbitrum合作，基于Orbit技术构建以太坊二层扩展，旨在实现股票代币化交易。该举措将推动加密生态发展，并可能在未来探索股权代币化交易，为散户提供更多投资机会。

2025-07-01 14:23

原研药信超妥在京东健康线上首发

转自：中华工商网 【记者姜虹北京报道】近日，高血压治疗新药信超妥®（沙库巴曲阿利沙坦钙片）在京东健康线上首发。该药由信立泰药业自主研发，是我国首个原研ARNI...

2025-06-25 16:57

[IN-DEPTH ANALYSIS] Zillow Unveiled: The Data-Driven Engine Behind U.S. Home Buying and Selling

TradingKey - Zillow Group is the top online real estate website in the United States. It’s where millions of people start when they want to buy, sell, or rent a home. Since it was founded in 2006, Zillow has changed the way people find homes by giving them easy access to home prices, listings, and h

2025-06-24 03:05

Telix Precision Medicine Announces AlFluor Radiochemistry Platform

_telix launches AlFluor™, a novel PET radiochemistry solution enabling flexible radiolabeling of PSMA with either ¹⁸F-AlF or ⁶⁸Ga. The platform supports centralized and distributed manufacturing, catering to clinical needs and physician preferences. Demonstrating comparable diagnostic performance to existing agents, AlFluor™ advances PSMA-PET imaging options._

2025-06-20 12:00

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Serina Therapeutics congratulates its partner Juvenescence on securing $150 million in Series B financing led by M42. This investment will establish a drug development hub in Abu Dhabi focused on AI-driven therapeutic innovations targeting age-related diseases, reflecting a partnership aimed at transforming medicine globally.

2025-06-17 10:00

山东新华制药股份(00719)获得沙库巴曲缬沙坦钠化学原料药上市申请批准通知书

金吾财讯 | 山东新华制药股份(00719)公布，收到国家药品监督管理局核准签发的沙库巴曲缬沙坦钠《化学原料药上市申请批准通知书》。 沙库巴曲缬沙坦钠片用于射血分数降低的慢性心力衰竭(NYHAⅡ-Ⅳ级，LVEF≤40%)成人患者，降低心血管死亡和心力衰竭住院的风险。沙库巴曲缬沙坦钠片可代替血管紧张素转化酶抑制剂(ACEI)或血管紧张素Ⅱ受体拮抗剂(ARB)，与其他心力衰竭治疗药物合用。沙库巴曲缬沙坦钠片也可用于治疗原发性高血压。

2025-06-11 16:42

Hyperscale Data Subsidiary TurnOnGreen Achieves $7.5 Million Backlog as Demand Grows for Mission-Critical Power Solutions

2025-06-11 10:30

Artisan Partners Asset Management Inc. Reports May 2025 Assets Under Management

Artisan Partners Asset Management Inc. reported $170.9 billion in preliminary assets under management as of May 31, 2025, with $83.4 billion in Artisan Funds and Global Funds, and $87.5 billion in separate accounts and other AUM.

2025-06-10 20:15

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics announced that the Scottish Medicines Consortium (SMC) has accepted LYTENAVA™ (bevacizumab gamma) for NHS Scotland patients with wet AMD. LYTENAVA™ is the first licensed ophthalmic formulation of bevacizumab for wet AMD in the UK, with a 10-year market exclusivity. The decision follows its commercial availability in the UK and positive clinical trial results. Outlook Therapeutics is collaborating with Cencora to support global commercial launch.

2025-06-10 12:05

巴拉圭把BTC定為法幣是假新聞？漲勢能否持續？

巴拉圭是否將比特幣認定為法幣，還需要進一步核實，因此不排除比特幣價格進一步上漲。

2025-06-10 06:16